Vivo Capital VIII LLC 13D/13G Filings for Agile Therapeutics, Inc. (AGRX)

Vivo Capital VIII LLC 13D and 13G filings for Agile Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-13
5:10 pm
Sale
2019-12-3113GAgile Therapeutics, Inc.
AGRX
Vivo Capital VIII LLC95
0.300%
-662decrease
(-87.50%)
Filing